Pituitary tumors contain a side population with tumor stem cell-associated characteristics

Endocrine-Related Cancer

Volumn 22, Issue 4, 2015, Pages 481-504

  Mertens, Freya ^a   Gremeaux, Lies ^a   Chen, Jianghai ^a,b   Fu, Qiuli ^a,c,d   Willems, Christophe ^a   Roose, Heleen ^a   Govaere, Olivier ^e   Roskams, Tania ^e   Cristina, Carolina ^f   Becú Villalobos, Damasia ^g   Jorissen, Mark ^h   Vander Poorten, Vincent ^h   Bex, Marie ^h   Van Loon, Johannes ^h   Vankelecom, Hugo ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Zhejiang Provincial Management Center of Water Resources   (China)

^d THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e DEPARTMENT OF IMAGING AND PATHOLOGY   (Belgium)

^f Universidad Nacional del Noroeste de la Provincia de Buenos Aires   (Argentina)

^g CONICET ^*  (Argentina)

^h UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Adenoma; Cancer stem cells; Cxcr4; Epithelial mesenchymal transition; Pituitary; Side population; Sox2; Stem cells; Tumor stem cells

Indexed keywords

AXIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; CHEMOKINE RECEPTOR CXCR4; DOPAMINE 2 RECEPTOR; EPIREGULIN; FIBRONECTIN; FRIZZLED PROTEIN; GELATINASE A; HOMEODOMAIN PROTEIN; INTERSTITIAL COLLAGENASE; KRUPPEL LIKE FACTOR 4; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LYMPHOID ENHANCER FACTOR 1; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH4 RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; TRANSCRIPTION FACTOR FOXC1; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNINDEXED DRUG; UVOMORULIN; VIMENTIN; VON WILLEBRAND FACTOR; WNT PROTEIN; DOPAMINE RECEPTOR; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CELL DEATH; CELL MIGRATION; CELL MOTILITY; CELL POPULATION; CELL PROLIFERATION; COLONY FORMING CELL; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; IMMUNOFLUORESCENCE; LYMPHOCYTE ACTIVATION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PITUITARY TUMOR CELL LINE; SIDE POPULATION CELL; SIGNAL TRANSDUCTION; TUMOR GROWTH; ADENOMA; ANIMAL; C57BL MOUSE; CELL LINE; GENETICS; HYPOPHYSIS; KNOCKOUT MOUSE; MIDDLE AGED; PATHOLOGY; SCID MOUSE; VERY ELDERLY; XENOGRAFT; YOUNG ADULT;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID; MIDDLE AGED; NEOPLASTIC STEM CELLS; PITUITARY GLAND; PITUITARY NEOPLASMS; RECEPTORS, DOPAMINE; SOXB1 TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; YOUNG ADULT;

EID: 84940102876     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-14-0546     Document Type: Article

References (61)

1. Andoniadou CL, Matsushima D, Mousavy Gharavy SN, Signore M, Mackintosh AI, Schaeffer M, Gaston-Massuet C, Mollard P, Jacques TS, Le Tissier P et al. 2013 Sox2+ stem/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential. Cell Stem Cell 13 433-445. (doi:10.1016/j.stem.2013.07.004)
2. Arnold K, Sarkar A, Yram MA, Polo JM, Sengupta S, Seandel M, Geijsen N & Hochedlinger K 2011 Sox2+ adult stem/progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell 9 317-329. (doi:10.1016/j.stem.2011.09.001)
3. Barbieri F, Bajetto A, Stumm R, Pattarozzi A, Porcile C, Zona G, Dorcaratto A, Ravetti J-L, Minuto F, Spaziante R et al. 2008 Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas. Clinical Cancer Research 14 5022-5032. (doi:10.1158/1078-0432.CCR-07-4717)
4. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ & Clevers H 2009 Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457 608-611. (doi:10.1038/nature07602)
5. Bertran E, Caja L, Navarro E, Sancho P, Mainez J, Murillo MM, Vinyals A, Fabra A & Fabregat I 2009 Role of CXCR4/SDF-1a in the migratory phenotype of hepatoma cells that have undergone epithelial-mesenchymal transition in response to the transforming growth factor-b. Cellular Signalling 21 1595-1606. (doi:10.1016/j.cellsig.2009.06.006)
6. Boumahdi S, Driessens G, Lapouge G, Rorive S, Nassar D, Le Mercier M, Delatte B, Caauwe A, Lenglez S, Nkusi E et al. 2014 SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature 511 246-250. (doi:10.1038/nature13305)
7. Britton KM, Eyre R, Harvey IJ, Stemke-Hale K, Browell D, Lennard TW & Meeson AP 2012 Breast cancer, side population cells and ABCG2 expression. Cancer Letters 323 97-105. (doi:10.1016/j.canlet.2012.03.041)
8. Chen J, Hersmus N, Van Duppen V, Caesens P, Denef C & Vankelecom H 2005 The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics. Endocrinology 146 3985-3998. (doi:10.1210/en.2005-0185)
9. Chen J, Gremeaux L, Fu Q, Liekens D, Van Laere S & Vankelecom H 2009 Pituitary progenitor cells tracked down by side population dissection Stem Cells 27 1182-1195. (doi:10.1002/stem.51)
10. Chen J, Li Y, Yu T-S, McKay RM, Burns DK, Kernie SG & Parada LF 2012 A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488 522-526. (doi:10.1038/nature11287)
11. Clevers H 2011 The cancer stem cell: premises, promises and challenges. Nature Medicine 17 313-319. (doi:10.1038/nm.2304)
12. Cristina C, Rubinstein M, Low MJ & Becu-Villalobos D 2006 Dopaminergic D2 receptor knockout mouse: an animal model of prolactinoma. Frontiers of Hormone Research 35 50-63. (doi:10.1159/000094308)
13. Daly AF, Tichomirowa MA & Beckers A 2009 The epidemiology and genetics of pituitary adenomas. Best Practice & Research. Clinical Endocrinology & Metabolism 23 543-554. (doi:10.1016/j.beem.2009.05.008)
14. Das B, Tsuchida R, Malkin D, Koren G, Baruchel S & Yeger H 2008 Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells 26 1818-1830. (doi:10.1634/stemcells.2007-0724)
15. De Craene B & Berx G 2013 Regulatory networks defining EMT during cancer initiation and progression. Nature Reviews. Cancer 13 97-110.(doi:10.1038/nrc3447)
16. Domanska UM, Timmer-Bosscha H, Nagengast WB, Munnink TH, Kliphuis NM & Huls G 2012 CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy. Neoplasia 14 709-718. (doi:10.1593/neo.12324)
17. Donangelo I, Ren S-G, Eigler T, Svendsen C & Melmed S 2014 Sca1C murine pituitary adenoma cells show tumor growth advantage. Endocrine-Related Cancer 21 203-216. (doi:10.1530/ERC-13-0229)
18. Dong J, Zhao Y, Huang Q, Fei X, Diao Y, Shen Y, Xiao H, Zhang T, Lan Q & Gu X 2011 Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation. Stem Cell Reviews 7 141-152. (doi:10.1007/s12015-010-9169-7)
19. Dworakowska D, Wlodek E, Leontiou CA, Igreja S, Cakir M, Teng M, Prodromou N, Góth MI, Grozinsky-Glasberg S, Gueorguiev M et al. 2009 Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors. Endocrine-Related Cancer 16 1329-1338. (doi:10.1677/ERC-09-0101)
20. Eppert K, Takenaka K, Lechman ER, Waldron L, Nilsson B, van Galen P, Metzeler KH, Poeppl A, Ling V, Beyene J et al. 2011 Stem cell gene expression programs influence clinical outcome in human leukemia. Nature Medicine 17 1086-1093. (doi:10.1038/nm.2415)
21. Fu Q, Gremeaux L, Luque RM, Liekens D, Chen J, Buch T, Waisman A, Kineman R & Vankelecom H 2012 The adult pituitary shows stem/progenitor cell activation in response to injury and is capable of regeneration. Endocrinology 153 1-12. (doi:10.1210/en.2012-1152)
22. Galland F, Lacroix L, Saulnier P, Dessen P, Meduri G, Bernier M, Gaillard S, Guibourdenche J, Fournier T, Evain-Brion D et al. 2010 Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis. Endocrine-Related Cancer 17 361-371. (doi:10.1677/ERC-10-0018)
23. Gatti M, Pattarozzi A, Bajetto A, Würth R, Daga A, Fiaschi P, Zona G, Florio T & Barbieri F 2013 Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity. Toxicology 314 209-220. (doi:10.1016/j.tox.2013.10.003)
24. Gremeaux L, Fu Q, Chen J & Vankelecom H 2012 Activated phenotype of the pituitary stem/progenitor cell compartment during the earlypostnatal maturation phase of the gland. Stem Cells and Development 20 801-813. (doi:10.1089/scd.2011.0496)
25. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ & Heeschen C 2007 Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1 313-323. (doi:10.1016/j.stem.2007.06.002)
26. Hofland LJ & Lamberts W 2002 Pituitary gland tumors. In Human Cell Culture. Cancer Cell Lines Part 1, ch 8, pp 149-159. Eds JRW Masters & B Palsson. Dordrecht: Springer. (doi:10.1007/0-306-46872-7-8)
27. Hölsken A, Gebhardt M, Buchfelder M, Fahlbusch R, Blümcke I & Buslei R 2011 EGFR signaling regulates tumor cell migration in craniopharyngiomas. Clinical Cancer Research 17 4367-4377. (doi:10.1158/1078-0432.CCR-10-2811)
28. Kato K, Takao T, Kuboyama A, Tanaka Y, Ohgami T, Yamaguchi S, Adachi S, Yoneda T, Ueoka Y, Kato K et al. 2010 Endometrial cancer sidepopulation cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage. American Journal of Pathology 176 381-392. (doi:10.2353/ajpath.2010.090056)
29. Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S & Sarkar FH 2010 Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS ONE 5 e12445. (doi:10.1371/journal.pone.0012445)
30. Lapouge G, Youssef KK, Vokaer B, Achouri Y, Michaux C, Sotiropoulou PA & Blanpain C 2011 Identifying the cellular origin of squamous skin tumors. PNAS 108 7431-7436. (doi:10.1073/pnas.1012720108)
31. Llaguno SA, Chen J, Kwon C, Jackson EL, Li Y, Burns DK, Alvarez-Buylla A & Parada LF 2009 Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 15 45-56. (doi:10.1016/j.ccr.2008.12.006)
32. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M et al. 2008 The epithelial- mesenchymal transition generates cells with properties of stem cells. Cell 133 704-715. (doi:10.1016/j.cell.2008.03.027)
33. Melmed S 2011 Pathogenesis of pituitary tumors. Nature Reviews. Endocrinology 7 257-266. (doi:10.1038/nrendo.2011.40)
34. Mitsuishi H, Kato T, Chen M, Cai L-Y, Yako H, Higuchi M, Yoshida S, Kanno N, Ueharu H & Kato Y 2013 Characterization of a pituitarytumor- derived cell line, TtT/GF, that expresses Hoechst efflux ABC transporter subfamily G2 and stem cell antigen 1. Cell and Tissue Research 354 563-572. (doi:10.1007/s00441-013-1686-7)
35. Morel A-P, Liévre M, Thomas C, Hinkal G, Ansieau S & Puisieux A 2008 Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 3 e2888. (doi:10.1371/journal.pone.0002888)
36. Moreno CS, Evans C-O, Zhan X, Okor M, DesiderioDM& Oyesiku NM2005 Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Research 65 10214-10222.(doi:10.1158/0008-5472.CAN-05-0884)
37. Moti N, Malcolm T, Hamoudi R, Mian S, Garland G, Hook CE, Burke GA, Wasik MA, Merkel O, Kenner L et al. 2014 Anaplastic large cell lymphoma-propagating cells are detectable by side population analysis and possess an expression profile reflective of a primitive origin. Oncogene 34 1843-1852. (doi:10.1038/onc.2014.112)
38. Mulholland DJ, Xin L, Morim A, Lawson D, Witte O & Wu H 2010 LinK Sca-1+ CD49fhigh stem/progenitors are tumor initiating cells in the Pten-null prostate cancer model. Cancer Research 69 8555-8562. (doi:10.1158/0008-5472.CAN-08-4673)
39. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K & Tang DG 2005 Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2C and ABCG2K cancer cells are similarly tumorigenic. Cancer Research 65 6207-6219. (doi:10.1158/0008-5472.CAN-05-0592)
40. Pfister O, Mouquet F, Jain M, Summer R, Helmes M, Fine A, Colucci WS & Liao R 2005 CD31K but not CD31C cardiac side population cells exhibit functional cardiomyogenic differentiation. Circulation Research 97 52-61. (doi:10.1161/01.RES.0000173297.53793.fa)
41. Pirozzi G, Tirino V, Camerlingo R, Franco R, La Rocca A, Liguori E, Martucci N, Paino F, Normanno N & Rocco G 2011 Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line. PLoS ONE 6 e21548. (doi:10.1371/journal.pone.0021548)
42. Ramsdell JS 1991 Transforming growth factor-α and -β are potent and effective inhibitors of GH4 pituitary tumor cell proliferation line. Endocrinology 128 1981-1990. (doi:10.1210/endo-128-4-1981)
43. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster AD & Segal RA 2003 A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. PNAS 100 13513-13518. (doi:10.1073/pnas.2235846100)
44. Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, van de Wetering M & Clevers H 2012 Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337 730-735. (doi:10.1126/science.1224676)
45. Taguchi T, Takao T, Iwasaki Y, Nishiyama M, Asaba K & Hashimoto K 2006 Suppressive effects of dehydroepiandrosterone and the nuclear factorκB inhibitor parthenolide on corticotroph tumor cell growth and function in vitro and in vivo. Journal of Endocrinology 188 321-331. (doi:10.1677/joe.1.06418)
46. Tirino V, Camerlingo R, Bifulco K, Irollo E, Montella R, Paino F, Sessa G, Carriero MV, Normanno N, Rocco G et al. 2013 TGF-b1 exposure induces epithelial to mesenchymal transition both in CSCs and non- CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction. Cell Death & Disease 4 e620. (doi:10.1038/cddis.2013.144)
47. Uezumi A, Ojima K, Fukada S, Ikemoto M, Masuda S, Miyagoe-Suzuki Y & Takeda S 2006 Functional heterogeneity of side population cells in skeletal muscle. Biochemical and Biophysical Research Communications 341 864-873. (doi:10.1016/j.bbrc.2006.01.037)
48. Vankelecom H 2010 Pituitary stem/progenitor cells: embryonic players in the adult gland? European Journal of Neuroscience 32 2063-2081. (doi:10.1111/j.1460-9568.2010.07523.x)
49. Vankelecom H 2012 Pituitary stem cells drop their mask. Current Stem Cell Research & Therapy 7 36-71. (doi:10.2174/157488812798483467)
50. Vankelecom H & Chen J 2014 Pituitary stem cells: where do we stand? Molecular and Cellular Endocrinology 385 2-17. (doi:10.1016/j.mce.2013.08.018)
51. Vankelecom H & Gremeaux L 2010 Stem cells in the pituitary gland: a burgeoning field. General and Comparative Endocrinology 166 478-488. (doi:10.1016/j.ygcen.2009.11.007)
52. Vanner RJ, Remke M, Gallo M, Selvadurai HJ, Coutinho F, Lee L, Kushida M, Head R, Morrissy S, Zhu X et al. 2014 Quiescent Sox2+ cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma. Cancer Cell 26 33-47. (doi:10.1016/j.ccr.2014.05.005)
53. Wu C & Alman BA 2008 Side population cells in human cancers. Cancer Letters 268 1-9. (doi:10.1016/j.canlet.2008.03.048)
54. Wu C, Wei Q, Utomo V, Nadesan P, Whetstone H, Kandel R, Wunder JS & Alman BA 2007 Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Research 67 8216-8222. (doi:10.1158/0008-5472.CAN-07-0999)
55. Xu M, Shorts-Cary L, Knox AJ, Kleinsmidt-DeMasters B, Lillehei K & WiermanME2009a Epidermal growth factor receptor pathway substrate 8 is overexpressed in human pituitary tumors: role in proliferation and survival. Endocrinology 150 2064-2071. (doi:10.1210/en.2008-1265)
56. Xu Q, Yuan X, Tunici P, Liu G, Fan X, Xu M, Hu J, Hwang JY, Farkas DL, Black KL et al. 2009b Isolation of tumour stem-like cells from benign tumours. British Journal of Cancer 101 303-311. (doi:10.1038/sj.bjc.6605142)
57. Yoon C-H, Kim M-J, Lee H, Kim R-K, Lim E-J, Yoo K-C, Lee G-H, Cui Y-H, Oh YS, Gye MC et al. 2012 PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population. Journal of Biological Chemistry 287 19516-19527. (doi:10.1074/jbc.M111.337428)
58. Yunoue S, Arita K, Kawano H, Uchida H, Tokimura H & Hirano H 2011 Identification of CD133C cells in pituitary adenomas. Neuroendocrinology 94 302-312. (doi:10.1159/000330625)
59. Zhu X, Gleiberman AS & Rosenfeld MG 2007 Molecular physiology of pituitary development: signaling and transcriptional networks. Physiological Reviews 87 933-963. (doi:10.1152/physrev.00006.2006)
60. Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT, Poppleton H, Zakharenko S, Ellison DW& Gilbertson RJ 2009 Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457 603-607. (doi:10.1038/nature07589)
61. Zhu Z, Khan MA, Weiler M, Blaes J, Jestaedt L, GeibertM, Zou P, Gronych J, Bernhardt O, Korshunov A et al. 2014 Targeting self-renewal in high-grade brain tumors leads to loss of brain tumor stem cells and prolonged survival. Cell Stem Cell 15 185-198. (doi:10.1016/j.stem.2014.04.007)